Nature Communications · 2022 · 53 citations · 50 references
Life SciencesGeneticsMolecular BiologyCancer GeneticsDna RepairMolecular OncologyDna DamageDna Double-strand Break RepairDna Repair DefectsDouble-strand Break RepairHomologous RecombinationSynthetic LethalityDna Damage Repair PathwaysDna Damage Response SignalingDna Double-strand BreaksDouble-strand Break Repair PathwaysDouble-strand Dna BreaksHomologous Recombination RepairSynthetic Lethal ScreeningTopoisomerase I-dna Complex Repair
Anticancer drugs, such as camptothecin (CPT), trap topoisomerase I (TOP1) on DNA and form TOP1 cleavage complexes (TOP1cc). Alternative repair pathways have been suggested in the repair of TOP1cc. However, how these pathways work with TDP1, a key repair enzyme that specifically hydrolyze the covalent bond between TOP1 catalytic tyrosine and the 3'-end of DNA and contribute to the repair of TOP1cc is poorly understood. Here, using unbiased whole-genome CRISPR screens and generation of co-deficient cells with TDP1 and other genes, we demonstrate that MUS81 is an important factor that mediates the generation of excess double-strand breaks (DSBs) in TDP1 KO cells. APEX1/2 are synthetic lethal with TDP1. However, deficiency of APEX1/2 does not reduce DSB formation in TDP1 KO cells. Together, our data suggest that TOP1cc can be either resolved directly by TDP1 or be converted into DSBs and repaired further by the Homologous Recombination (HR) pathway.
50